Delivery Order SPE2DB20D2104-SPE2DB24FV04R

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,158.06 contract is for the delivery of JANUVIA 100 MG TABLET 90S, a diabetes medication. The award has an ultimate completion date of July 5, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,172.62, is for the delivery of JANUVIA 100 MG TABLET 1000S, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and a completion date of December 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $15,478.56 firm fixed-price contract is for the supply of JANUVIA 100 MG tablets. The contract has an ultimate completion date of November 18, 2024 and was awarded on November 15, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract that AmerisourceBergen holds with the DLA Troop Support Medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,650.95, is for the supply of JANUVIA 100 MG TABLET 1000S, a prescription medication used to treat type 2 diabetes. The contract is a firm fixed-price delivery order with a completion date of June 7, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
This is a $5,091.21 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which enables the company to supply a...
This is a Delivery Order federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $3,224.26 contract is for the supply of JANUVIA 100 MG TABLET 90S, a prescription medication used to treat type 2 diabetes. The contract has a firm fixed price and an ultimate completion date of July 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUVIA 100 MG TABLET 90S, a medication used in the treatment of diabetes, with a ceiling value of $5,472.00 and a period of performance through January 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order valued at $47,780.99 with a firm fixed price and a performance period through June 2025. It is for the delivery of JANUVIA 100 MG TABLET 1000S, a medication used to treat diabetes. The contract is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,091.46 firm fixed-price contract is for the supply of JANUVIA 100 MG TABLET 90S, a prescription medication, with a performance period through July 3, 2025. The contract is not set-aside and represents an individual delivery order against Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,357.52 contract is for the supply of JANUVIA 100 MG TABLET 90S, a prescription medication. The award has an ultimate completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen, valued at up to...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FV04R
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,559.94 firm-fixed-price contract is for the supply of JANUVIA 100 MG TABLET 1000S, a medication used to treat diabetes. The contract has a period of performance through July 9, 2024.

The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:56 AM